Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading
- $301,336.35
- $143,180,968.46
- July 2, 2024
- Christopher Richard Anzalone
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 12, 2021 | CFO | 13,038 | $81.02 | Sell | $1,056,338.76 | |
| Jan. 7, 2021 | Insider | 15,625 | $75.00 | Sell | $1,171,875.00 | |
| Jan. 6, 2021 | CFO | 30,625 | $72.44 | Sell | $2,218,475.00 | |
| Jan. 6, 2021 | General Counsel | 25,000 | $72.41 | Sell | $1,810,250.00 | |
| Jan. 5, 2021 | SVP | 19,375 | $72.53 | Sell | $1,405,268.75 | |
| Jan. 4, 2021 | Director | 4,000 | $76.08 | Sell | $304,320.00 | |
| Dec. 17, 2020 | Director | 9,575 | $79.32 | Sell | $759,489.00 | |
| Dec. 10, 2020 | Director | 3,000 | $71.26 | Sell | $213,780.00 | |
| Dec. 9, 2020 | CEO | 38,676 | $69.06 | Sell | $2,670,964.56 | |
| Nov. 19, 2020 | Insider | 19,500 | $69.39 | Sell | $1,353,105.00 | |
| Oct. 23, 2020 | CEO | 100,000 | $58.21 | Sell | $5,821,000.00 | |
| Oct. 20, 2020 | CFO | 29,166 | $54.04 | Sell | $1,576,130.64 | |
| Oct. 9, 2020 | Director | 10,000 | $48.00 | Sell | $480,000.00 | |
| Aug. 13, 2020 | CEO | 50,000 | $41.35 | Sell | $2,067,500.00 | |
| June 25, 2020 | CEO | 100,000 | $38.81 | Sell | $3,881,000.00 | |
| June 15, 2020 | Director | 500 | $31.33 | Buy | $15,665.00 | |
| May 12, 2020 | Director | 36,000 | $35.83 | Sell | $1,289,880.00 | |
| April 27, 2020 | COO | 300 | $40.00 | Sell | $12,000.00 | |
| April 20, 2020 | COO | 23,515 | $40.00 | Sell | $940,600.00 | |
| April 14, 2020 | Director | 25,000 | $36.89 | Sell | $922,250.00 | |
| March 16, 2020 | Director | 500 | $23.94 | Buy | $11,970.00 | |
| March 11, 2020 | Director | 500 | $28.60 | Buy | $14,300.00 | |
| Feb. 27, 2020 | Director | 500 | $35.07 | Buy | $17,535.00 | |
| Jan. 21, 2020 | CFO | 40,313 | $49.44 | Sell | $1,993,074.72 | |
| Jan. 13, 2020 | Director | 500 | $54.95 | Buy | $27,475.00 | |
| Jan. 6, 2020 | CFO | 20,000 | $60.11 | Sell | $1,202,200.00 | |
| Jan. 6, 2020 | COO | 35,613 | $60.13 | Sell | $2,141,409.69 | |
| Jan. 6, 2020 | General Counsel | 14,625 | $60.12 | Sell | $879,255.00 | |
| Dec. 12, 2019 | CEO | 100,000 | $67.50 | Sell | $6,750,000.00 | |
| Dec. 2, 2019 | CEO | 37,967 | $69.15 | Sell | $2,625,418.05 | |
| Nov. 1, 2019 | CFO | 37,884 | $40.85 | Sell | $1,547,561.40 | |
| Oct. 10, 2019 | CEO | 56,325 | $31.83 | Sell | $1,792,824.75 | |
| Sept. 24, 2019 | CEO | 66,645 | $28.20 | Sell | $1,879,389.00 | |
| Sept. 20, 2019 | CEO | 4,250 | $29.00 | Sell | $123,250.00 | |
| Sept. 11, 2019 | Director | 85,000 | $30.00 | Sell | $2,550,000.00 | |
| Sept. 9, 2019 | Director | 100,000 | $28.90 | Sell | $2,890,000.00 | |
| June 26, 2019 | Director | 17,756 | $27.61 | Sell | $490,243.16 | |
| May 28, 2019 | General Counsel | 30,000 | $24.88 | Sell | $746,400.00 | |
| May 21, 2019 | CFO | 27,071 | $22.00 | Sell | $595,562.00 | |
| April 3, 2019 | CEO | 50,000 | $19.30 | Sell | $965,000.00 | |
| March 1, 2019 | COO | 42,500 | $19.99 | Sell | $849,575.00 | |
| Feb. 26, 2019 | Director | 65,000 | $19.25 | Sell | $1,251,250.00 | |
| Feb. 25, 2019 | COO | 42,500 | $18.98 | Sell | $806,650.00 | |
| Feb. 22, 2019 | Director | 3,000 | $18.05 | Sell | $54,150.00 | |
| Feb. 19, 2019 | CFO | 8,000 | $18.00 | Sell | $144,000.00 | |
| Feb. 19, 2019 | COO | 68,750 | $17.86 | Sell | $1,227,875.00 | |
| Feb. 15, 2019 | COO | 26,250 | $17.67 | Sell | $463,837.50 | |
| Feb. 12, 2019 | COO | 242,834 | $16.04 | Sell | $3,895,057.36 | |
| Feb. 8, 2019 | COO | 46,167 | $15.34 | Sell | $708,201.78 | |
| Feb. 5, 2019 | COO | 22,500 | $14.48 | Sell | $325,800.00 |
Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.
The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, Bruce D Given, Patrick O'brien, Douglas B Given, James C Hamilton, Douglas B. Given, Backer Marianne De, Martin Javier San, William D Waddill, Mauro Ferrari, Michael S Perry, Adeoye Y Olukotun, Charles Mckenney, David L Lewis, Hongbo Lu, James Hassard, Tracie Oliver, Victoria Vakiener, Zhen Li, Peter Brian Leone, and Edward W Frykman
The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 28 trades.
Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $63,729,086.06.
Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.
The most recent insider trade for Arrowhead Pharmaceuticals Inc was on July 2, 2024.
The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.
The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.